Period of time： 2003年10期
Publisher： Elsevier
Founded in： 1977
Total resources： 2
ISSN： 0149-2918
Subject： R4 Clinical Medicine
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Clinical Therapeutics,volume 25,issue 10
Menu
An overview of infliximab, etanercept, efalizumab, and alefacept as biologic therapy for psoriasis
Clinical Therapeutics,volume 25,issue 10 , Vol. 25, Iss. 10, 2003-10 , pp.
Access to resources
Recommend
Newer antiepileptic drugs: Possible uses in the treatment of neuropathic pain and migraine
Clinical Therapeutics,volume 25,issue 10 , Vol. 25, Iss. 10, 2003-10 , pp.By Leonardi A., Abelson M.B. in (2003)
Clinical Therapeutics,volume 25,issue 10 , Vol. 25, Iss. 10, 2003-10 , pp.Absolute oral bioavailability of rosuvastatin in healthy white adult male volunteers
By Martin P.D., Warwick M.J., Dane A.L., Brindley C., Short T. in (2003)
Clinical Therapeutics,volume 25,issue 10 , Vol. 25, Iss. 10, 2003-10 , pp.By Edward Hogan R., Garnett W.R., Thadani V.M., Carbatrol Study Group in (2003)
Clinical Therapeutics,volume 25,issue 10 , Vol. 25, Iss. 10, 2003-10 , pp.Use of gabapentin for postherpetic neuralgia: Results of two randomized, placebo-controlled studies
By Stacey B.R., Glanzman R.L. in (2003)
Clinical Therapeutics,volume 25,issue 10 , Vol. 25, Iss. 10, 2003-10 , pp.A medicare Rx benefit: So close and yet so far
By Coons S.J., Vogel R.J. in (2003)
Clinical Therapeutics,volume 25,issue 10 , Vol. 25, Iss. 10, 2003-10 , pp.By Bos J.M., Rumke H., Welte R., Postma M.J. in (2003)
Clinical Therapeutics,volume 25,issue 10 , Vol. 25, Iss. 10, 2003-10 , pp.By Bolaman Z., Kadikoylu G. in (2003)
Clinical Therapeutics,volume 25,issue 10 , Vol. 25, Iss. 10, 2003-10 , pp.
Previous
Next